ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7
ISL1 预测胃癌患者的预后不良,并通过与 SETD7 结合 ZEB1 启动子来推动肿瘤进展
期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-018-1278-2
Ting Guo, Xian-Zi Wen, Zi-Yu Li, Hai-Bo Han, Chen-Guang Zhang, Yan-Hua Bai, Xiao-Fang Xing, Xiao-Jing Cheng, Hong Du, Ying Hu, Xiao-Hong Wang, Yong-Ning Jia, Meng-Lin Nie, Meng Xie, Qing-Da Li, Jia-Fu Ji